Clinical Trials Logo

Citation(s)

A Phase 0 Master Protocol Using the CIVO® Platform to Evaluate Intratumoral Microdoses of Anti-Cancer Therapies in Patients With Solid Tumors

Details for clinical trial NCT04541108